Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2025-12-25 @ 3:13 AM
NCT ID:
NCT04730505
Eligibility Criteria:
Inclusion Criteria:
* Patient is ≥ 18 years old with a diagnosis of Multiple Myeloma
* Patient must reside in the USA.
* Patients within each of the following subgroups, at one of the following timepoints, will be eligible for entry:
1. Newly-diagnosed multiple myeloma transplant-eligible
2. Patients undergoing their first ASCT
3. Newly-diagnosed multiple myeloma transplant-ineligible
4. Relapsed and/or refractory.
Exclusion Criteria:
* Patient has a condition(s) that, in the opinion of the Investigator, would make participation infeasible such as inability to provide informed consent, illiteracy, or inability to speak, read, and write in English.
* Patient is on hospice.
* Patient is receiving or has received an investigational agent \< 28 days prior to randomization or during this pilot study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04730505
Study Brief:
Protocol Section:
NCT04730505